Invest in Ourotech
Ourotech takes the guesswork out of cancer treatment by giving doctors a way to test treatment methods on your cells outside your body.
Time Left to Invest
XX days : XX hours : XX minutes
Purchased securities are not currently tradeable. Expect to hold your investment until the company lists on a national exchange or is acquired.
QUINN is offering securities under both Regulation D and Regulation CF through SI Securities, LLC ("SI Securities"). SI Securities is an affiliate of Slice Capital, Inc, a registered broker-dealer, and member FINRA/SIPC. SI Securities will receive cash compensation equal to 5% of the value of the securities sold. Investments made under both Regulation D and Regulation CF involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest. Furthermore, the contents of the Highlights, Term Sheet sections have been prepared by SI Securities and shall be deemed broker-dealer communications subject to FINRA Rule 2210 (the “Excluded Sections”). With the exception of the Excluded Sections noted above, this profile contains offering materials prepared solely by World's Best without the assistance of SI Securities, and not subject to FINRA Rule 2210 (the “Issuer Profile”). The Issuer Profile may contain forward-looking statements and information relating to, among other things, the company, its business plan and strategy, and its industry. Investors should review the risks and disclosures. The contents below are meant to be a summary of the information found in the company’s Form C. Before making an investment decision, investors should review the company’s Form C for a complete description of its business and offering information, a copy of which may be found both hereand below.